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Background: 20-Fucosyllactose (2-FL) is a functional oligosaccharide present in human milk which protects against
the infection of enteric pathogens. Because 2-FL can be synthesized through the enzymatic fucosylation of lactose
with guanosine 50-diphosphate (GDP)-L-fucose by α-1,2-fucosyltransferase (FucT2), an 2-FL producing Escherichia coli
can be constructed through overexpressing genes coding for endogenous GDP-L-fucose biosynthetic enzymes and
heterologous fucosyltransferase.
Results: The gene for FucT2 from Helicobacter pylori was introduced to the GDP-L-fucose producing recombinant E. coli
BL21 star(DE3) strain. However, only small amount of 2-FL was produced in a batch fermentation because the E. coli
BL21star(DE3) strain assimilated lactose instead of converting to 2-FL. As an alternative host, the E. coli JM109(DE3) strain
which is incapable of assimilating lactose was chosen as a 2-FL producer. Whole cell biosynthesis of 2-FL from lactose
was investigated in a series of batch fermentations using various concentrations of lactose. The results of batch
fermentations showed that lactose was slowly assimilated by the engineered E. coli JM109(DE3) strain and 2-FL was
synthesized without supplementation of another auxiliary sugar for cell growth. A maximum 2-FL concentration of
1.23 g/l was obtained from a batch fermentation with 14.5 g/l lactose. The experimentally obtained yield (g 2-FL/g
lactose) corresponded to 20% of the theoretical maximum yield estimated by the elementary flux mode (EFM) analysis.
Conclusions: The experimental 2-FL yield in this study corresponded to about 20% of the theoretical maximum yield,
which suggests further modifications via metabolic engineering of a host strain or optimization of fermentation
processes might be carried out for improving 2-FL yield. Improvement of microbial production of 2-FL from lactose by
engineered E. coli would increase the feasibility of utilizing 2-FL as a prebiotic in various foods.
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analysisBackground
Human milk oligosaccharides (HMOs) are known to be
the most relevant factor for the development of intestinal
microbiota in breast-fed infants [1]. Also, HMOs have
been reported to play important roles in preventing ad-
hesion of pathogens and toxins to epithelial surfaces [2].
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reproduction in any medium, provided the orN-fucopentaose and lacto-N-difucohexaose, are common
HMOs. Fucosylated oligosaccharides act as growth
stimulating factors for select Bifidobacteria and soluble
analogs of receptors for pathogenic bacteria, thereby pro-
tecting infants against infection from enteric pathogens
and binding of toxins [3,4]. Specifically, α-1,2-linked fuco-
sylated oligosaccharides are reported to exhibit protective
activity against several pathogens including Campylobacter
jejuni [3,5], Salmonella enteric serotype Typhimurium [6],
Enterotoxigenic E. coli [7], Helicobacter pylori [8] and nor-
oviruses [9]. Among them, 20-fucosyllactose (2-FL) is the
most abundant fucosyloligosaccharide in human milk and
accounts for more than 30% of total HMOs [3,5]. Low. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reported to be associated with a higher rate of diarrhea in
breast-fed infants [3]. Hence, 2-FL is a promising oligosac-
charide for nutraceutical and pharmaceutical purposes.
2-FL can be synthesized through the enzymatic fucosyla-
tion of lactose by α-1,2 fucosyltransferase (FucT2), which
requires guanosine 50-diphosphate (GDP)-L-fucose as a
donor of L-fucose [10]. Escherichia coli is known to be
able to synthesize GDP-L-fucose since GDP-L-fucose is
used for biosynthesis of colanic acid, one of the main com-
ponents of the cell wall [11]. Therefore, 2-FL can be pro-
duced via engineering of the GDP-L-fucose biosynthetic
pathway and overexpression of the fucosyltransferase gene
in metabolically engineered E. coli. Figure 1 shows the
metabolic pathway for biosysnthesis of GDP-L-fucose and
2-FL in recombinant E. coli.
Previously, biosynthesis of fucosyloligosaccharides using
a recombinant microorganism and fucosyltransferase has
been reported. The enzymatic synthesis of 2-FL was exam-
ined by using purified FucT2, GDP-L-fucose and lactose
[10], however, the high cost of GDP-L-fucose and FucT2
purification may be a limiting factor for large-scale pro-
duction of fucosyloligosaccharides. Production of several
fucose-containing lacto-oligosaccharides in recombinant E.
coli was also reported through simultaneous overexpres-
sion of fucosyltransferase and the regulatory protein for
colanic acid biosynthesis [12,13], which suggested that
whole cell synthesis of fucosyloligosaccharides through dir-
ect amplification of the GDP-L-fucose biosynthesis might
be feasible.Figure 1 The metabolic pathway for GDP-L-fucose and 20-fucosyllacto
enzymes are abbreviated as follows; ManA, mannose 6-phosphate isomeras
guanylyltransferase; Gmd, GDP-D-mannose-4,6-dehydratase; WcaG, GDP-4-k
α-1,2-fucosyltransferase. Pi, GDP and GTP denote phosphate, guanosine 50-dTo construct an efficient 2-FL production system by
metabolic engineering, an understanding and detailed
analysis of a cellular metabolic network involved in the
2-FL biosynthesis is important. Elementary flux mode
(EFM) analysis has emerged as a powerful tool for meta-
bolic pathway analysis. EFM analysis is a useful mathem-
atical tool for defining and describing all metabolic
routes that are both stoichiometrically and thermo-
dynamically feasible for a group of enzymes. The EFM
analysis can decompose a complex metabolic network of
many highly interconnected reactions into uniquely
organized pathways that support steady state of metabol-
ism. EFM analysis can provide identification of all genet-
ically independent pathways, determination of the most
efficient physiological state of a cell, and analysis of
metabolic network properties such as robustness and
regulation [14-16]. Hence, it can be a useful tool for
understanding dynamics of cellular metabolism and ra-
tional design of the host strain’s metabolism for 2-FL
production.
We have previously developed a recombinant E. coli
system for efficient production of GDP-L-fucose by
metabolic engineering. An enhancement of GDP-
L-fucose production was achieved by modulation of
several factors for biosynthesis of GDP-L-fucose such
as amplification of GDP-D-mannose biosynthesis, re-
generation of NADPH and manipulation of the
guanosine nucleotides biosynthetic pathway [17-19].
In the present study, the GDP-L-fucose production sys-
tem was applied for efficient production of 2-FL byse (2-FL) biosynthesis in recombinant E. coli. The names of
e; ManB, phosphomannomutase; ManC, mannose 1-phosphate
eto-6-deoxymannose 3,5-epimerase 4-reductase; FucT2,
iphosphate and guanosine 50-triphosphate.
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into the recombinant E. coli able to overproduce GDP-L-
fucose. Whole cell biosynthesis of 2-FL from lactose was
assessed in a series of batch fermentations for recombinant
E. coli overexpressing the necessary genes for GDP-
L-fucose production and the FucT2. An EFM analysis for
2-FL production in the recombinant E. coli was used to
compare and evaluate experimental results.
Methods
Strains and plasmids
E. coli TOP10 [F- mcrA Δ(mrr-hsdRMS-mcrBC)
φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu) 7697
galU galK rpsL (StrR) endA1 nupG] was used for genetic
manipulation. E. coli BL21star(DE3) [F−, ompT, hsdSB
(rB
−mB
−), gal, dcm rne131 (DE3)] (Invitrogen, Carlsbad,
CA, USA) and JM109(DE3) [endA1 glnV44 thi-1 relA1
gyrA96 recA1 mcrB+ Δ(lac-proAB) e14- [F' traD36
proAB+ lacIq lacZΔM15] hsdR17(rK
- mK
+) (DE3)] (NEB,
Ipswich, MA, USA) were used for production of GDP-
L-fucose and 2-FL. Plasmid pmBCGW containing the
polycistronic gmd-wcaG gene cluster and manB-manC
gene cluster was previously constructed using plasmid
pETDuet-1 [18]. The gene encoding FucT2 was obtained
by the polymerase chain reactions (PCR) using the gen-
omic DNA of the Helicobacter pylori 26695 strain
(ATCC 700392) as template [20]. Two PCR primers of
fucT2_F and fucT2_R were used for the amplification of
the fucT2 gene. After digestion of PCR fragments of the
fucT2 gene and pCOLADuet-1 (Merck Biosciences,
Darmstadt, Germany) with NcoI and SacI, the DNA frag-
ments were ligated to construct plasmid pHfucT2. Plas-
mids and primers used in this work are listed in Table 1.
The constructed plasmid was confirmed by DNA se-
quencing. The conditions for PCR reaction, DNA ma-
nipulation and bacterial transformation followed the
descriptions in the previous study [21].
Batch fermentation
Batch fermentation was carried out in a 250 ml flask
containing 50 ml of LB medium at 25°C and pH 6.8.Table 1 List of primers and plasmids used in this study





pETDuet-1 two T7 promoters with two MCS, pBR322 rep
pCOLADuet-1 two T7 promoters with two MCS, ColA replico
pmBCGW derived from pETDuet-1, PT7-manB-manC (Nco
pHfucT2 derived from pCOLADuet-1, PT7- fucT2 (NcoI/SAgitation speed was maintained at 250 rpm. When dry
cell mass reached 0.3 g/l, 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) was added to culture
broth. After 3 h of additional cultivation, 2.6 g/l (or
14.5 g/l) lactose was added for 2-FL production.
Analytical methods
Cell concentration was measured by optical density
(OD) at 600 nm using a spectrophotometer (Biomate
5, Thermo, NY, USA). Overexpression of FucT2 inside
the cell was analyzed by using sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE,
12% polyacrylamide). After 3 h of 0.1 mM IPTG in-
duction, cells were collected and the concentration
was adjusted to around 7.2 g/l. They were resus-
pended in 50 mM potassium phosphate buffer (pH
7.0) and disrupted by an ultrasonic processor. After
centrifugation at 15,000 × g for 20 min, the super-
natant (soluble fraction) and debris (insoluble frac-
tion) were separated. Ten microliters of the soluble
protein fraction (approximately 0.04 mg) and the
same volume of the total and insoluble protein frac-
tions were subjected to SDS-PAGE. Gels were stained
with Coomassie brilliant blue solution and images
were analyzed using a densitometer.
Concentrations of lactose, 2-FL and acetate in batch
fermentations were determined by using a high perform-
ance liquid chromatography (HPLC) system (Agilent
Technologies 1200 Series) equipped with a Rezex ROA
Organic Acid H+ column (Phenomenex, Torrance, CA,
USA) and a refractive index (RI) detector (Agilent, Palo
Alto, CA, USA). The column was eluted with 0.01 N
H2SO4 at a flow rate of 0.6 ml/min at 50°C.
In order to confirm 2-FL biosynthesis, culture broth at the
end of the batch fermentation was collected and analyzed
using a liquid chromatography/mass spectrometry (LC/MS)
system. The LC (Agilent Technologies 1100 Series) was
equipped with an Agilent Zorbax Eclipse ZDB-C8 (4.6x150
mm, 5 μm) column and an Agilent LC/MSD Trap XCT Plus
detector. The column was eluted at a flow rate of




licon (copy number ~40), Ampr Merck Biosciences
n (copy number 10 ~ 12), Kanr Merck Biosciences
I/SacI)-PT7-gmd-wcaG (NdeI/XhoI)-TT7, Amp
r Lee et al., 2009
acI)-PT7-MCS2-TT7, Kan
r this study
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eluent B (acetonitrile) for 1 min; 5% to 95% eluent B
over 6 min; 95% eluent B over 10 min. The scan
range for MS was 70–600 mass-to-charge ratio (m/z).
Construction of metabolic network model for E. coli
producing 2-FL from lactose
A metabolic network model was constructed for 2-FL
producing E. coli that grows on lactose. The E. coli net-
work was based on a model that was introduced by Stel-
ling et al. [22] to examine the relationship between
structure and function in metabolic networks. Further-
more, the model has been used for calculating elemen-
tary flux modes in previous reports [23,24]. The
metabolic network was composed of 108 reactions,
which were involved in carbon central metabolism,
amino acid synthesis, fatty acid synthesis and biomass
production (Additional file 1). The catabolic part of the
model included substrate uptake reactions, glycolysis,
pentose phosphate pathway, TCA cycle, and excretion of
by-products (e.g. acetate, formate, lactate, and ethanol).
Previous networks were extended to include the ana-
plerotic reactions (e.g. malic enzyme and pyruvate oxi-
dase) in addition to parallel pathways for initial acetate
metabolism. The anabolic part of the model covers the
conversion of precursors into building blocks like macro-
molecules and biomass. The core E. coli model from
Stelling et al. [22] was modified in this research to ac-
count for lactose consumption and synthesis of 2-FL.
Among the reactions added for 2-FL synthesis, some
minor adjustments were made to simplify the model.
Lactose was assumed to break down to 2 moles of glu-
cose because galactose can be easily converted into glu-
cose-6-phosphate. ATP was used in place of GTP for
energy transfer. As for the mass balance, it should be
noted that ADP is formed whenever ATP is consumed
for all the metabolic reactions in the network. The mass
balance equation on ATP is therefore the negative of the
mass balance on ADP and thus the two equations are
linearly dependent. Therefore, ADP can be excluded
from the model in order to simplify the subsequent EFM
calculation. The same is true for other cofactor pairs like
NADP/NADPH and NAD/NADH. The EFM pathways
in the model were estimated using METATOOL 5.1
[14,16] with Matlab.
Results
Expression of α-1,2-fucosyltransferase (FucT2) in
recombinant E. coli
The expression pattern of FucT2 was investigated during
a batch fermentation of recombinant E. coli harboring
plasmid pHfucT2. In order to maximize the expression
of the soluble form of FucT2 in the recombinant E. coli,
0.1 mM of IPTG was used. As shown in Figure 2, a33 kDa protein (consistent with FucT2, [20]) was found
in both soluble and insoluble fraction. While a signifi-
cant amount of FucT2 was expressed in inclusion bod-
ies, biosynthesis of 2-FL was expected because a soluble
form of FucT2 was available as well.Batch fermentations
From the preliminary experiments (whole cell bioconver-
sion of 2 g/l lactose with E. coli BL21star(DE3) strain),
we concluded that the E. coli BL21star(DE3) strain is not
beneficial for 2-FL production because it consumed lac-
tose for growth and maintenance instead of converting
to 2-FL (data not shown). Some E. coli strains, such as
DH5α and JM series, are known to be unable to assimi-
late lactose or utilize lactose extremely inefficiently due
to partial deletion of the lacZ gene, which codes for
β-galactosidase. As such, these E. coli strains might be
useful for 2-FL production. Hence, E. coli JM109(DE3)
enabling overexpressing proteins under the control of T7
promoter was chosen as an alternative host stain for
2-FL production.
2-FL production for BL21star(DE3) and JM109(DE3)
was compared under batch fermentation conditions. In
order to allow sufficient production of both GDP-
L-fucose biosynthetic enzymes and FucT2 inside the
cells, the cells were cultivated for 3 h after 0.1 mM IPTG
induction. Then, 2.6 g/l of lactose was added to initiate
2-FL production without addition of additional sugar be-
cause GDP-L-fucose can be produced from LB media
[17,18]. During the fermentations, extracellular 2-FL pro-
duction (in the medium) was monitored by HPLC ana-
lysis. As a result, a small amount of 2-FL (10 mg/l) was
produced in the batch fermentation of recombinant E.
coli BL21star(DE3). Meanwhile, much higher amount of
2-FL was produced in the batch fermentation of recom-
binant E. coli JM109(DE3). About 140 mg/l of 2-FL was
produced from 2.6 g/l of lactose while 0.4 g/l of lactose
remained unused at the end of the fermentation (data
not shown). These results suggest that the lactose con-
centration should be controlled at more than 0.5 g/l to
maintain 2-FL production. Consequently, a yield of
60 mg 2-FL/g lactose was obtained from the batch fer-
mentation of E. coli JM109(DE3) when 2.6 g/l of lactose
was used. In order to obtain a higher amount of 2-FL, a
batch fermentation with a higher concentration of lac-
tose was carried out. Figure 3 shows the profiles of lac-
tose consumption and 2-FL production in the batch
fermentation of recombinant E. coli JM109(DE3) with
14.5 g/l lactose. The cells consumed lactose slowly but
produced 2-FL constantly for 96 h. After 96 h of fermen-
tation, the 2-FL concentration did not increase any fur-
ther and lactose consumption stopped. As a result, a
maximum 2-FL concentration of 1.23 g/l was obtained,
Figure 2 SDS-PAGE analysis of the cell crude extract of recombinant E. coli BL21star(DE3) strains harboring pCOLADuet-1 and pHfucT2,
respectively. Cells were harvested after 3 h of 0.1 mM IPTG induction. T, S and I denote total, soluble and insoluble protein fractions, respectively.
The arrow indicates the corresponding protein band with the estimated molecular weight of FucT2. Lane M indicates size marker.
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increase as compared with the previous fermentation with
2.6 g/l lactose. 2- FL yield increased to 90 mg 2-FL/g lactose
when 14.5 g/l of lactose was used. This improvement might
be caused from increased lactose availability inside the cell.
The results of the batch fermentations are summarized in
Table 2.Figure 3 Profile of 2-FL production in the batch fermentation of recom
and pHfucT2. After 3 h of 0.1 mM IPTG induction, 14.5 g/l of lactose was a
cell mass; green triangle, 2-FL concentration; blue square, lactose concentrat
acetate and 2-FL concentrations were done by three independent experim
fermentations.Confirmation of 2-FL biosynthesis by recombinant E. coli
overexpressing GDP-L-fucose biosynthetic enzymes and
FucT2
LC/MS analysis was performed to confirm the biosyn-
thesis of 2-FL in the recombinant E. coli JM109(DE3)
strain overexpressing ManB, ManC, Gmd, WcaG and
FucT2. HPLC data showed that a compound with thebinant E. coli JM109(DE3) strain harboring plasmids pmBCGW
dded for 2-FL production. Symbols denote as follows; grey circle, dry
ion; red square, acetate concentration. Measurement of cell, lactose,
ents. Symbols in the figure show the representative values of the batch
Table 2 Summary of batch fermentations of E. coli strains producing 2-FL from lactose








BL21star(DE3) pmBCGW+pHfucT2 2.56 ± 0.04 1.84 ± 0.05 0.01 ± 0.001 0.005 ± 0.001
JM109(DE3) pmBCGW+pHfucT2 2.55 ± 0.02 1.17 ± 0.05 0.14 ± 0.015 0.06 ± 0.005
14.54 ± 0.67 1.70 ± 0.28 1.23 ± 0.011 0.09 ± 0.004
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ture broth (Figure 4B). MS scanning data (compound
with RT= 6.6 min) showed ion fragment of m/z 487.1,
which is compatible with 2-FL (Figure 4C).Evaluation of 2-FL yield using EFM analysis for 2-FL
producing E. coli from lactose
In order to evaluate the efficiency of 2-FL production
from lactose using the recombinant E. coli JM109
(DE3) strain, elementary flux mode (EFM) analysis
was employed to estimate a maximum theoretical
yield of 2-FL from lactose. Figure 5 shows the predic-
tion of theoretical 2-FL yield versus biomass yield for
E. coli growing on lactose. Our experimental result
from a batch fermentation of 14.5 g/l of lactose
resulted in a biomass yield of 0.1 g biomass/g lactose.
This suggests that 2-FL production from lactose by
the engineered E. coli reached 20% of the maximum
2-FL production capacity.Figure 4 LC/MS analysis of 2-FL biosynthesis in the batch fermentatio
ManC, Gmd, WcaG and FucT2. At the end of batch fermentation, culture
HPLC analysis of 100 mg/l 2-FL standard solution (A), HPLC analysis of cultu
MS analysis of the compound with the retention time= 6.6 min in the cultuDiscussion
In human milk, α-1,2-fucosylated oligosaccharides such as
2-FL, are known to have protective activity against patho-
genic bacteria and their toxins [3,5,9]. Hence, the availabil-
ity of large amounts of α-1,2-fucosylated oligosaccharides
would be useful in ready-to-use materials, drugs for funda-
mental investigations or therapeutic purposes. As biosyn-
thesis of GDP-L-fucose, a key compound for biosynthesis
of α-1,2-fucosylated oligosaccharides, requires a number of
enzymes and cofactors such as NADPH and GTP, a
whole-cell conversion approach might be more realistic
for industrial production than other chemical or enzymatic
approaches [25].
In previous studies, improvements of GDP-L-fucose pro-
duction in recombinant E. coli were attempted by manipu-
lating the pathways enabling GDP-L-fucose biosynthesis
from glucose [17-19]. This study was undertaken to up-
grade the GDP-L-fucose production system for 2-FL pro-
duction through additional overexpression of FucT2. To
this end, the fucT2 gene from H. pylori was cloned andn of the recombinant E. coli JM109(DE3) overexpressing ManB,
broth was collected for confirmation of extracellular 2-FL production.
re broth of E. coli JM109(DE3) harboring pmBCGW+pHfucT2 (B) and
re broth of E. coli JM109(DE3) harboring pmBCGW+pHfucT2 (C).
Figure 5 Calculation of the theoretical maximum yield of 2-FL
from lactose. Elementary flux mode (EFM) analysis was carried out
for 2-FL producing E. coli.
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an insoluble form of FucT2 was a major expression form,
an active FucT2 was also observed in the recombinant E.
coli as shown in Figure 2. With the aid of FucT2 overex-
pression, recombinant E. coli BL21star(DE3) could pro-
duce 2-FL in the batch fermentation with 2.6 g/l lactose.
However, 2-FL yield was fairly low (5 mg 2-FL/g lactose).
E. coli BL21star(DE3) seemed to assimilate lactose instead
of converting to 2-FL. Most of the initially added lactose
was consumed within 12 h of fermentation with a marginal
growth during the fermentation (data not shown). These
results suggested that E. coli BL21star(DE3) is not appro-
priate for 2-FL production.
Previously, several attempts for production of fucosy-
lated (or sialylated) oligosaccharides from lactose have
been made using the derivative of E. coli JM107 and
JM109 since these strains are unable to produce an active
β-galactosidase due to the insertion of the M15 single
strand DNA into the lacZ gene [12,13,26,27]. In these
cases, glucose (or glycerol) was used as another carbon
source for GDP-fucose production (or CMP-N-acetylneur-
aminic acid). These nucleotide sugars are subsequently
used for fucosylation (or sialylation). According to the pre-
vious reports, E. coli JM109(DE3) was chosen as an alter-
native host strain for 2-FL production. As expected, the
use of E. coli JM109(DE3) allowed production of a consid-
erable amount of 2-FL in the batch fermentation, corre-
sponding to a 14-fold increase in 2FL concentration
compared with the value obtained in BL21star(DE3) strain.
However, a theoretical yield of 2-FL from lactose was pre-
dicted to be 1.4 g 2-FL/g lactose when cells cannot utilize
lactose for growth. Meanwhile, our experimental yield of
2-FL was only about 0.1 g 2-FL/g lactose. This result indi-
cates that more than 90% of lactose consumed was usedfor other purposes such as biomass production and endo-
geneous metabolism. Slow consumption of lactose was
also observed in the batch fermentation with mixed sugars
(2 g/l of lactose and 5 g/l of mannose), where we expected
that lactose could be mainly used for 2-FL production as
mannose might be used for cell growth. Although an en-
hancement of 2-FL yield (0.13 g 2-FL/g lactose) was
obtained, most of the consumed lactose was not used for
2-FL production (data not shown). It is probable that
incompletely inactivated β-galactosidase or cryptic β-
galactosidase inside the cell might cause the reduction of
2-FL yield from lactose. Insertion of λ(DE3) into the gen-
ome might cause the slow assimilation of lactose, which
was supported by a previous report that α-complementa-
tion of LacZ was observed with the insertion of the DE3
cassette into the genomic DNA of E. coli JM101 [26].
Since slow consumption of lactose and production of
biomass were observed in the batch fermentation with
2.6 g/l lactose, another batch fermentation with a high
concentration of lactose (14.5 g/l) was conducted in
order to obtain a higher amount of 2-FL. Generally, E.
coli is known to produce acetate when growing on an ex-
cessive sugar even under aerobic conditions. However,
JM109(DE3) strain showed no acetate production even
when excessive amounts (14.5 g/l) of lactose were added
as displayed in Figure 3. It is generally known that acet-
ate formation is accelerated when the metabolic fluxes to
pyruvate exceed the capacity of the respiratory metabol-
ism [28,29]. Slow consumption of lactose might not lead
to acetate formation, suggesting that the lactose
utilization rate by E. coli JM109(DE3) is not fast enough
to cause acetate formation. This result could be benefi-
cial for designing a 2-FL production process such as a
fed-batch type operation since acetate formation is
known to be one of the main problems occurring in fed-
batch type operations of E. coli [17]. However, low yield
and productivity of 2-FL from lactose will need to be
improved for industrial applications. The 2-FL produc-
tion system in this study was verified by comparing the
experimental 2-FL yield with the theoretical maximum
yield estimated by the EFM analysis. 2-FL yield corre-
sponded to about 20% of the theoretical maximum yield,
which suggests further modifications via metabolic en-
gineering of a host strain or optimization of fermentation
processes should be carried out for improvement of 2-FL
yield. Increased FucT2 solubility and intracellular lactose
availability may be considered as primary approaches for
improvement of 2-FL yield.
Conclusions
In this study, construction of efficient 2-FL production
system was attempted. The fucT2 gene from H. pylori
was introduced into the recombinant E. coli able to over-
produce GDP-L-fucose and biosynthesis of 2-FL was
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http://www.microbialcellfactories.com/content/11/1/48observed in the batch fermentation with lactose. The
2-FL production system using the E. coli JM109(DE3)
strain showed a low rate of lactose assimilation and pro-
duced a considerable amount of 2-FL in the simple batch
fermentation without acetate formation. The experimen-
tal 2-FL yield corresponded to 20% of the theoretical
maximum yield, which indicates that more research
should be conducted. Efficient microbial 2-FL produc-
tion may be useful for utilizing 2-FL as a nutraceutical
compound for various applications.
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